Evidence map›Paper›PMID 29073062›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Small-molecule inhibitors directly target CARD9 and mimic its protective variant in inflammatory bowel disease.

Elizaveta S Leshchiner, Jason S Rush, Michael A Durney, Zhifang Cao, Vlado Dančík, Benjamin Chittick, Huixian Wu, Adam Petrone, Joshua A Bittker, Andrew Phillips and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Pharmacological targeting of adaptor proteins in chronic inflammation.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. The role of the CBM complex in allergic inflammation and disease.The Journal of allergy and clinical immunology · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. CARD9 Mediates Pancreatic Islet Beta-Cell Dysfunction Under the Duress of Hyperglycemic Stress.Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology · 2022
    Article
  16. Article
  17. CARD9 Regulation and its Role in Cardiovascular Diseases.International journal of biological sciences · 2022
    Review
  18. CARD9 Signaling, Inflammation, and Diseases.Frontiers in immunology · 2022
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Elizaveta S LeshchinerDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138.
Jason S RushCenter for the Development of Therapeutics, Broad Institute, Cambridge, MA 02142.
Michael A DurneyCenter for the Development of Therapeutics, Broad Institute, Cambridge, MA 02142.
Zhifang CaoGastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
Vlado DančíkCenter for the Science of Therapeutics, Broad Institute, Cambridge, MA 02142.
Benjamin ChittickCenter for the Science of Therapeutics, Broad Institute, Cambridge, MA 02142.
Huixian WuCenter for the Science of Therapeutics, Broad Institute, Cambridge, MA 02142.
Adam PetroneCenter for the Development of Therapeutics, Broad Institute, Cambridge, MA 02142.
Joshua A BittkerCenter for the Development of Therapeutics, Broad Institute, Cambridge, MA 02142.
Andrew PhillipsCenter for the Development of Therapeutics, Broad Institute, Cambridge, MA 02142.
Jose R PerezCenter for the Development of Therapeutics, Broad Institute, Cambridge, MA 02142.
Alykhan F ShamjiCenter for the Science of Therapeutics, Broad Institute, Cambridge, MA 02142.
Virendar K KaushikCenter for the Development of Therapeutics, Broad Institute, Cambridge, MA 02142.
Mark J DalyMedical and Population Genetics Program, Broad Institute, Cambridge, MA 02142.
Daniel B GrahamGastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
Stuart L SchreiberDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138; stuart_schreiber@harvard.edu xavier@molbio.mgh.harvard.edu.
Ramnik J XavierGastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114; stuart_schreiber@harvard.edu xavier@molbio.mgh.harvard.edu.
Broad Institute · USMassachusetts General Hospital · USHarvard University · US

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
SYNTHESIS OF MATERIALS WITH PHYSIOLOGICAL PROPERTIESR01GM038627 · NIGMS · YALE UNIVERSITY · PI SCHREIBER, STUART L · 1987 to 2017
$10.5M
Functional characterization of CARD9 genetic variants in fungal immunityR01AI137325 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI XAVIER, RAMNIK J · 2018 to 2022
$3.5M
SYNTHESIS OF MATERIALS WITH PHYSIOLOGICAL PROPERTIESR37GM038627 · NIGMS · HARVARD UNIVERSITY · PI SCHREIBER, STUART L · 1992 to 2001
$1.1M
Howard Hughes Medical InstituteNIAID NIH HHS R01 AI137325NIDDK NIH HHS P30 DK043351NIGMS NIH HHS R01 GM038627NIGMS NIH HHS R37 GM038627
6 · The paper itself

Abstract

Advances in human genetics have dramatically expanded our understanding of complex heritable diseases. Genome-wide association studies have identified an allelic series of

Indexed as

Genetic VariationCARD Signaling Adaptor ProteinsDrug Evaluation, PreclinicalEnzyme-Linked Immunosorbent AssayGenetic MarkersHigh-Throughput Screening AssaysHumansInflammatory Bowel DiseasesProtein BindingSensitivity and SpecificityTripartite Motif ProteinsUbiquitin-Protein LigasesCARD9 protein, humanCARD Signaling Adaptor ProteinsGenetic MarkersTRIM62 protein, humanTripartite Motif ProteinsUbiquitin-Protein LigasesCARD9inflammatory bowel diseasesmall moleculestherapeutics

Identifiers

PMID29073062
PMCPMC5664502
OpenAlexW2762692859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.